Eu Yan Sang Data Pack – Strategy, Report, RMIT University

GUIDELINES: This data-pack includes essential readings for Assignments 1,2, and 3.

Read and apply relevant insights about our case study organisation and its industry.

ORGANISATION | Eu Yan Sang is the case study organisation that forms the basis of Assignments 1,2 and 3.

One of Singapore’s oldest homegrown brands Eu Yan Sang will be acquired by Japan’s Rohto Pharmaceutical and Mitsui & Co. The deal for the 144-year-old Traditional Chinese Medicine firm is valued at $800 million. Eu Yan Sang operates over 170 retail outlets and 30 TCM clinics, mainly in Singapore, Hong Kong and Malaysia. The deal is expected to be completed around 30 June.

View the films in Canvas that give extra organisation context information

REFERENCES | These references are a starting point only. You are encouraged to undertake wider research beyond these sources.

As all students are using the same references ignore the high similarity for this section in the Turnitin similarity score
If the links are broken, please contact the Library staff

COMPANY INSIGHTS|

Brand Asia – Eu Yan Sang Singapore: Leveraging the Strong Heritage to Propel into the Future

Building on a Trusted Brand

Eu Yan Sang: The founding story of the Traditional Chinese Medicine business set to be acquired for $594M. April 18, 2024

How Singapore-based Eu Yan Sang grew from one shop to a household name

https://www.euyansang.com.sg/en/about-us/eyscorporate1.html

https://www.euyansang.com/en_AU/home

https://sg.euyansangclinic.com/

https://sg.euyansangclinic.com/our-businesses

https://www.euyansang.com.sg/en/our-milestones/milestonearticle.html

https://en.wikipedia.org/wiki/Eu_Yan_Sang#:~:text=Eu%20Yan%20Sang%20makes%20use,improve%20TCM%20products%20and%20treatments.

Mitsui to acquire Eu Yan Sang International Ltd, a leading Singapore-based consumer healthcare brand in Asia with Rohto.. Apr. 4, 2024

Reuters, 2024. Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang. April 4,

CNN | Eu Yan Sang to be acquired by Japan’s Rohto Pharma, Mitsui for $800m

FACEBOOK FILM | How Eu Yan Sang went from a medicine shop to a S$800m buyout

INDUSTRY INSIGHTS|

Business Research Insights, 2024. Traditional Chinese Medicine (TCM) Market Report Overview. Updated 03 June.

IBIS WORLD, 2024, Traditional Chinese Medicine Manufacturing in China industry trends (2019-2024). May 2024.

IBIS WORLD, 2024. Traditional Chinese Medicine Manufacturing – Market Size (2004–2029). Updated May 25.

Industry Insights Guru, 2024. Traditional Chinese Medicine Market: Exploring Trends and Global Forecast 2031 | Industry Research Biz. Feb. 9

Olanday, C, 2024. These health and wellness leaders are combining traditional Chinese medicine with modern breakthroughs. Feb 09.

Persistence Market Research, 2024. Traditional Chinese Medicine Market Outlook (2023-2033)

Statista, 2018. Pharmaceutical market size in Asia in 2018, by country or territory

The post Eu Yan Sang Data Pack – Strategy, Report, RMIT University appeared first on Singapore Assignment Help.